Literature DB >> 1350349

Effects of blockade of 5-HT2 receptors and activation of 5-HT1A receptors on the exploratory activity of rats in the elevated plus-maze.

V Motta1, S Maisonnette, S Morato, P Castrechini, M L Brandão.   

Abstract

Acute administration of gepirone, a 5-HT1A agonist, caused a dose dependent (1-10 mg/kg, IP) reduction in the locomotor activity (open and closed arms) of rats tested in the elevated plus-maze. However, rats housed in individual cages and submitted to chronic treatment with gepirone (10 mg/kg PO) showed a marked increase in the percentages of number and time spent in the open arms as compared to controls. These results are compatible with the idea that the antiaversive effect due to long-term treatment with 5-HT1A agonists is the result of a progressive desensitization of the somatodendritic 5-HT autoreceptor with the consequent recovery of firing rate of 5-HT neurons along with an activation of normosensitive postsynaptic 5-HT neurons. Ketanserin caused a biphasic effects on the exploratory behavior of rats in the plus-maze. The lower dose (0.5 mg/kg) decreased the aversion to the open arms and the higher dose (1.0 mg/kg) caused an unspecific decrease in the overall activity of the animals. Ketanserin is supposed to have antagonistic action on 5-HT2 and on alpha-adrenergic receptors. As prazosin (0.5-1.0 mg/kg), an alpha-adrenergic receptor blocker, did not present any significant effect in the present work it is suggested that the effects of the lower dose of ketanserin was due to its high antagonistic action on 5-HT2 receptors.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1350349     DOI: 10.1007/bf02244978

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  22 in total

1.  Effects of 5-HT1A receptor agonists and L-5-HTP in Montgomery's conflict test.

Authors:  B Söderpalm; S Hjorth; J A Engel
Journal:  Pharmacol Biochem Behav       Date:  1989-01       Impact factor: 3.533

2.  Serotonergic mechanisms in the behavioral effects of buspirone and gepirone.

Authors:  A S Eison; M S Eison; M Stanley; L A Riblet
Journal:  Pharmacol Biochem Behav       Date:  1986-03       Impact factor: 3.533

3.  Receptor binding profile of R 41 468, a novel antagonist at 5-HT2 receptors.

Authors:  J E Leysen; F Awouters; L Kennis; P M Laduron; J Vandenberk; P A Janssen
Journal:  Life Sci       Date:  1981-03-02       Impact factor: 5.037

4.  Behavioural evidence for a functional interaction between central 5-HT2 and 5-HT1A receptors.

Authors:  L I Backus; T Sharp; D G Grahame-Smith
Journal:  Br J Pharmacol       Date:  1990-08       Impact factor: 8.739

5.  Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat.

Authors:  S Pellow; P Chopin; S E File; M Briley
Journal:  J Neurosci Methods       Date:  1985-08       Impact factor: 2.390

6.  Anticonflict effect of the putative serotonin receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT).

Authors:  J A Engel; S Hjorth; K Svensson; A Carlsson; S Liljequist
Journal:  Eur J Pharmacol       Date:  1984-10-15       Impact factor: 4.432

7.  Gepirone in anxiety: a pilot study.

Authors:  I Csanalosi; E Schweizer; W G Case; K Rickels
Journal:  J Clin Psychopharmacol       Date:  1987-02       Impact factor: 3.153

8.  Effects in the X-maze anxiety model of agents acting at 5-HT1 and 5-HT2 receptors.

Authors:  M A Critchley; S L Handley
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

9.  Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat.

Authors:  S Pellow; S E File
Journal:  Pharmacol Biochem Behav       Date:  1986-03       Impact factor: 3.533

10.  Effects of gepirone, an aryl-piperazine anxiolytic drug, on aggressive behavior and brain monoaminergic neurotransmission.

Authors:  B A McMillen; S M Scott; H L Williams; M K Sanghera
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-04       Impact factor: 3.000

View more
  7 in total

Review 1.  5-HT1A receptor-regulated signal transduction pathways in brain.

Authors:  Abigail M Polter; Xiaohua Li
Journal:  Cell Signal       Date:  2010-04-02       Impact factor: 4.315

2.  Cerebral tryptophan hydroxylase activity, and 5-HT1A receptor, 5-HT2A receptor, and 5-HT transporter binding in grouped and isolated Roman RHA and RLA rats: relationships with behaviours in two models of anxiety.

Authors:  A Kulikov; N Castanon; P Mormède; F Chaouloff
Journal:  Psychopharmacology (Berl)       Date:  1995-10       Impact factor: 4.530

Review 3.  5HT drugs in animal models of anxiety.

Authors:  S L Handley; J W McBlane
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

4.  Social deprivation enhances the vulnerability of male Wistar rats to stressor- and amphetamine-induced behavioral sensitization.

Authors:  S H Ahmed; L Stinus; M Le Moal; M Cador
Journal:  Psychopharmacology (Berl)       Date:  1995-01       Impact factor: 4.530

5.  Ethological evaluation of the effects of acute and chronic buspirone treatment in the murine elevated plus-maze test: comparison with haloperidol.

Authors:  J C Cole; R J Rodgers
Journal:  Psychopharmacology (Berl)       Date:  1994-03       Impact factor: 4.530

Review 6.  5-HT1A receptor agonists: recent developments and controversial issues.

Authors:  J De Vry
Journal:  Psychopharmacology (Berl)       Date:  1995-09       Impact factor: 4.530

7.  Behavioral Effects of Systemic, Infralimbic and Prelimbic Injections of a Serotonin 5-HT2A Antagonist in Carioca High- and Low-Conditioned Freezing Rats.

Authors:  Laura A León; Vitor Castro-Gomes; Santiago Zárate-Guerrero; Karen Corredor; Antonio P Mello Cruz; Marcus L Brandão; Fernando P Cardenas; J Landeira-Fernandez
Journal:  Front Behav Neurosci       Date:  2017-07-07       Impact factor: 3.558

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.